| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.148 | 1.113 | - | 8.361 | 7.550 | 4.995 | 4.349 | 1.852 | 975 | 1.460 |
| Total Income - EUR | 1.148 | 1.113 | - | 8.361 | 7.550 | 4.995 | 4.349 | 1.852 | 975 | 1.460 |
| Total Expenses - EUR | 1.066 | 620 | - | 1.004 | 965 | 45 | 1.745 | 162 | 0 | 0 |
| Gross Profit/Loss - EUR | 82 | 493 | - | 7.357 | 6.585 | 4.950 | 2.605 | 1.690 | 975 | 1.460 |
| Net Profit/Loss - EUR | 47 | 460 | - | 7.106 | 6.358 | 4.800 | 2.475 | 1.634 | 822 | 1.262 |
| Employees | 1 | 1 | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pamed Company S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 224 | 711 | - | 14.960 | 20.731 | 25.214 | 3.908 | 2.151 | 1.288 | 2.582 |
| Inventories | 0 | 0 | - | 0 | 211 | 207 | 263 | 629 | 627 | 623 |
| Receivables | 0 | 0 | - | 0 | 0 | 0 | 0 | 19 | 0 | 0 |
| Cash | 224 | 711 | - | 14.960 | 20.520 | 25.007 | 3.645 | 1.503 | 661 | 1.958 |
| Shareholders Funds | -25.384 | -25.125 | - | -10.523 | -3.961 | 914 | 3.368 | 319 | 1.141 | 2.396 |
| Social Capital | 337 | 334 | - | 322 | 316 | 310 | 303 | 304 | 303 | 302 |
| Debts | 25.608 | 25.836 | - | 25.483 | 24.692 | 24.300 | 540 | 1.832 | 147 | 186 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9700 - 9700" | |||||||||
| CAEN Financial Year |
9700
|
|||||||||
Comments - Pamed Company S.r.l.